Skip to main content

UBS Group AG

Position in KURA — Kura Oncology, Inc.

CIK 1610520 ZURICH, V8

Position in KURA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,582,055
+$2,124,962 QoQ
Shares Held
964,636
-7.3% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in KURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. KURA ranks #112 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KURA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,582,055 964,636
2026-03-31 $8,457,093 1,040,233
2025-12-31 $11,013,658 1,060,025
2025-09-30 $4,297,293 485,570
2025-06-30 $647,872 112,283
2025-03-31 $920,864 139,525
2024-12-31 $2,747,787 315,475
2024-09-30 $2,536,603 129,816
2024-06-30 $1,889,688 91,777
2024-03-31 $4,838,091 226,821
2023-12-31 $2,918,521 202,957
2023-09-30 $750,985 82,345
2023-06-30 $179 17
2023-03-31 $2,618,930 214,140
2022-12-31 $2,667,355 214,936
2022-09-30 $453,935 33,231
2022-06-30 $1,122,674 61,248
2022-03-31 $3,036,208 188,819
2021-12-31 $2,307,298 164,807
2021-09-30 $214,346 11,444
2021-06-30 $283,621 13,603
2021-03-31 $1,639,631 57,999
2020-12-31 $228,195 6,987
2020-09-30 $172,625 5,634
2020-06-30 $4,058 249
2020-03-31 $164,672 16,550